-

SHAREHOLDER ALERT: Robbins LLP Announces That MoneyGram International, Inc. (MGI) is Being Sued for Misleading Shareholders

SAN DIEGO & DALLAS--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of MoneyGram International, Inc. (NASDAQ: MGI) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between June 17 2019 and February 22, 2021.

If you suffered a loss due to MoneyGram International Inc.'s misconduct, click here.

MoneyGram International, Inc. (MGI) Misled Investors About

According to the complaint, on June 17, 2019, MoneyGram announced it was entering into a strategic partnership with Ripple Labs, Inc. Ripple is a blockchain technology company and the developer of cryptocurrency XRP. As part of the partnership, Ripple agreed to invest up to $50 million in MoneyGram stock. On this news, the price of MoneyGram stock increased over 150%. Throughout the relevant period, MoneyGram touted the partnership, stating that it will reduce our working capital needs and generate additional earnings and cash flows." The Company also made statements regarding the strong contribution that market development fees received from Ripple made to MoneyGram's financial results.

On December 22, 2020, the Securities and Exchange Commission ("SEC") filed a lawsuit against Ripple, alleging that Ripple's cryptocurrency XRP is an unregistered security in violation of the securities laws. With regard to MoneyGram's involvement, the SEC complaint explains that the major non-investment use of the XRP cryptocurrency is transferring money on Ripple's ODL platform and that in order to convince anyone to use ODL to transfer money, Ripple had to make a $50 million equity investment and pay sufficient financial compensation to an entity referred to as the "Money Transmitter," i.e., MoneyGram. The SEC complaint further explains how MoneyGram took park in the sale of unregistered XRP securities on the open market.

On February 22, 2021, MoneyGram filed its annual report on Form 10-K for the year ended December 31, 2020, stating: "MoneyGram ceased transacting with Ripple under the commercial agreement in early December 2020 and has not resumed trading. It is possible that MoneyGram will not resume transacting with Ripple … and will be unable to receive the related market development fees in 2021 and beyond." On this news, MoneyGram stock fell 33.2%, from a closing price of $10.87 on February 19, 2021, to $7.26 on February 23, 2021.

If you purchased shares of MoneyGram International Inc. (MGI) between June 17, 2019 and February 22, 2021, you have until April 30, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against MoneyGram International, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Reminds Primo Brands Corporation Stockholders on the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the PRMB class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada. Who is part of the class? The case purportedly represents stockholders who purchased or otherwise acquired (i) the co...

Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the class period? February 21, 2025 - August 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or acquired Telix securities during the class peri...

Robbins LLP Reminds Freeport-McMoran Inc. Stockholders of the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the FCX class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Freeport-McMoran Inc. (NYSE: FCX) is a mining company. What is the class period? February 15, 2022 - September 24, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport during the class period because the Company allegedly misled investors regarding safety at its mines. For more information, submit a form, email attorney Aaron Dumas, Jr....
Back to Newsroom